Insider Stock Trading History of Palekar Rohan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Palekar Rohan since year 2005. The trader's CIK number is 1423327. At the time of this reporting, Palekar Rohan is the SVP & Chief Commercial Officer of Avanir Pharmaceuticals . (stock ticker symbol AVN). See this page for all insider trading activities at Avanir Pharmaceuticals .

Note that in the past PALEKAR ROHAN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Palekar Rohan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-11-28 AVNR Avanir Pharmaceuticals Sale 15,000 15.00 225,000
2014-09-15 AVNR Avanir Pharmaceuticals Sale 25,000 11.25 281,250
2013-12-17 AVNR Avanir Pharmaceuticals Buy 10,000 2.80 28,000
2013-11-04 AVNR Avanir Pharmaceuticals Buy 10,000 4.19 41,900
2012-12-13 AVNR Avanir Pharmaceuticals Buy 10,000 2.46 24,600
2011-04-20 MDVN Medivation, Inc. Sale 12,500 22.63 282,825
2011-04-20 MDVN Medivation, Inc. Option Ex 12,500 15.71 196,375
2011-03-21 MDVN Medivation, Inc. Sale 7,500 16.05 120,375
2010-05-17 MDVN Medivation, Inc. Sale 2,500 10.91 27,270
2010-02-01 MDVN Medivation, Inc. Option Ex 12,500 15.71 196,375
2010-02-01 MDVN Medivation, Inc. Sale 17,500 33.59 587,825
2009-12-07 MDVN Medivation, Inc. Option Ex 10,000 15.71 157,100
2009-12-07 MDVN Medivation, Inc. Sale 12,000 33.27 399,240
2009-09-10 MDVN Medivation, Inc. Sale 5,576 25.78 143,743
2009-09-09 MDVN Medivation, Inc. Sale 6,424 26.00 166,991
2009-09-10 MDVN Medivation, Inc. Option Ex 3,576 15.71 56,178
2009-09-09 MDVN Medivation, Inc. Option Ex 6,424 15.71 100,921
2009-06-30 MDVN Medivation, Inc. Option Ex 10,000 15.71 157,100
2009-06-30 MDVN Medivation, Inc. Sale 12,000 22.21 266,568
2009-03-18 MDVN Medivation, Inc. Sale 10,000 16.30 163,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Palekar Rohan (SVP & Chief Commercial Officer of Avanir Pharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.